Business Description
Vivo Bio Tech Ltd
NAICS : 325412
ISIN : INE380K01017
Compare
Compare
Traded in other countries / regions
511509.India IPO Date
2017-03-03Description
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.97 | |||||
| Debt-to-EBITDA | 2.19 | |||||
| Interest Coverage | 1.64 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.43 | |||||
| Beneish M-Score | -2.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.6 | |||||
| 3-Year EBITDA Growth Rate | -1.1 | |||||
| 3-Year EPS without NRI Growth Rate | -28.8 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.75 | |||||
| 9-Day RSI | 45.4 | |||||
| 14-Day RSI | 47.51 | |||||
| 3-1 Month Momentum % | -14.13 | |||||
| 6-1 Month Momentum % | -15.34 | |||||
| 12-1 Month Momentum % | -0.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.54 | |||||
| Quick Ratio | 1.24 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 598.03 | |||||
| Days Sales Outstanding | 91.06 | |||||
| Days Payable | 57.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | -7.55 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88.99 | |||||
| Operating Margin % | 27.08 | |||||
| Net Margin % | 15.94 | |||||
| FCF Margin % | 16.19 | |||||
| ROE % | 13.43 | |||||
| ROA % | 5.8 | |||||
| ROIC % | 7.99 | |||||
| 3-Year ROIIC % | -1.02 | |||||
| ROC (Joel Greenblatt) % | 18.02 | |||||
| ROCE % | 17.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.69 | |||||
| PE Ratio without NRI | 7.69 | |||||
| Shiller PE Ratio | 13 | |||||
| PEG Ratio | 0.88 | |||||
| PS Ratio | 1.29 | |||||
| PB Ratio | 0.92 | |||||
| Price-to-Tangible-Book | 1.05 | |||||
| Price-to-Free-Cash-Flow | 8.16 | |||||
| Price-to-Operating-Cash-Flow | 3.98 | |||||
| EV-to-EBIT | 6.53 | |||||
| EV-to-EBITDA | 4.25 | |||||
| EV-to-Revenue | 2.41 | |||||
| EV-to-FCF | 14.75 | |||||
| Price-to-GF-Value | 1.24 | |||||
| Price-to-Projected-FCF | 5.91 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.67 | |||||
| Price-to-Graham-Number | 0.6 | |||||
| Earnings Yield (Greenblatt) % | 15.29 | |||||
| FCF Yield % | 13.59 | |||||
| Forward Rate of Return (Yacktman) % | -2.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivo Bio Tech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 467.765 | ||
| EPS (TTM) (₹) | 4.82 | ||
| Beta | 1.09 | ||
| 3-Year Sharpe Ratio | -0.28 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 28.26 | ||
| 14-Day RSI | 47.51 | ||
| 14-Day ATR (₹) | 2.180264 | ||
| 20-Day SMA (₹) | 38.1085 | ||
| 12-1 Month Momentum % | -0.79 | ||
| 52-Week Range (₹) | 31.2 - 56 | ||
| Shares Outstanding (Mil) | 14.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivo Bio Tech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivo Bio Tech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vivo Bio Tech Ltd Frequently Asked Questions
What is Vivo Bio Tech Ltd(BOM:511509)'s stock price today?
The current price of BOM:511509 is ₹37.32. The 52 week high of BOM:511509 is ₹56.00 and 52 week low is ₹31.20.
When is next earnings date of Vivo Bio Tech Ltd(BOM:511509)?
The next earnings date of Vivo Bio Tech Ltd(BOM:511509) is .
Does Vivo Bio Tech Ltd(BOM:511509) pay dividends? If so, how much?
Vivo Bio Tech Ltd(BOM:511509) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers